Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Ambulatory infusion aids in management of chronic disease conditions such as cancer, cancer related pain, hemophilia, immune deficiencies, Crohn’s disease, congestive heart failure, rheumatoid arthritis, multiple sclerosis, dehydration, malnutrition, and chronic inflammatory diseases. Ambulatory infusions may be provided by variety of organizations such as hospitals, community pharmacies, and home health agencies. Ambulatory infusion is administration of various types of medications and fluids intravenously into the bloodstream by the help of needle or catheter.     

The global ambulatory infusion center market is estimated to be valued at US$ 47,013.5 million in 2020 and is expected to exhibit a CAGR of 9.0% during the forecast period (2020-2027).

Figure 1. Global Ambulatory Infusion Center Market Value (US$ Mn), 2016-2027

Ambulatory Infusion Center  | Coherent Market Insights

The increasing prevalence of cancer is expected to propel growth of the global ambulatory infusion center market during the forecast period. For instance, according to the Our World in Data, an organization focusing on research and data of world’s largest health problems, stated that, in 2017, globally 9.6 million people were estimated to have died from the various types of cancer and also stated that, in 2017, every sixth death caused in the world was due to cancer.

Furthermore, key companies focusing on service launches such as ambulatory infusion centers for chemotherapy is expected to propel growth of the global ambulatory infusion center market during the forecast period. For instance, in June 2020, Cedar-Sinai launched Samuel Oschin Cancer Center in Los Angeles, a center with 45,000-square-foot outpatient facility, providing ambulatory infusion services for cancer patients.

request-sample

Ambulatory Infusion Center Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 47,013.5 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 9.0% 2027 Value Projection: US$ 51,244.7 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of the Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Therapy Type: Blood Product Infusion, Iron Therapy, Steroid Infusion, Immunoglobulin Therapy, Therapeutic Phlebotomy, Plasmapheresis, Clotting Factor Replacement Therapy, Others.
  • By Application: Chronic Inflammatory Disorders, Neurological Disorders, Cancers, Nutrition Support, Gastro-intestinal Disorders.
  • By Distribution Channel: Hospital, Clinics, Home Infusion.
Companies covered:

Option Care Health, PharmaScript, Cleveland Clinic, Stoughton Health, Coram CVS, Hattiesburg Clinic, UnitedHealth Group, UK HealthCare, CHI Health, PharMerica, Beacon Health System, Inc., Arnot Health, Inc. , IVX Health and Precision Healthcare

Growth Drivers:
  • Increasing prevalence of various diseases such as cancer, multiple sclerosis, and gastrointestinal diseases, globally
  • Key players focusing on inorganic growth strategies such as mergers and acquisitions
Restraints & Challenges:
  • Ambulatory infusion leads to various side effects such as itching at infusion site, flushing, nausea, and cough in patients.

Global Ambulatory Infusion Center Market – Impact of Coronavirus (COVID-19)

Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it a public health emergency. According to the World Health Organization’s report, manifestation of coronavirus (COVID-19) has resulted in over 65.1 million infected individuals worldwide as of December 3, 2020.

COVID-19 pandemic has affected the ambulatory infusion center market negatively, owing to increasing risk of coronavirus infection spread, while carrying out infusion procedures. Therefore various academic institutes and research institutes are guiding safety procedures during the administration of various medication through infusion procedures to avoid the COVID-19 infections. According to American College of Rheumatology report published in April 2020, stated that healthcare professionals can carry out following safety precaution guidelines to decrease the risk of spreading COVID-19 infections during ambulatory infusion procedures:

  • Clean and decontaminate facilities frequently using a disinfectant known to be effective, and ensure the appropriate contact time for the disinfectant
  • All equipment and high-touch surfaces in patient care areas should be cleaned and disinfected between each patient use, along with special attention to other high-touch surfaces in check-in areas and around the facility
  • Inform patients of social distancing and hygiene procedures
  • Adjust waiting rooms to allow for social distancing, placing chairs six feet or more apart, and consider asking patients to wait for their appointment outside the facility
  • Hand sanitizer should be readily available in patient care areas

Figure 2. Global Ambulatory Infusion Center Market Share (%), By Region, 2020

Ambulatory Infusion Center  | Coherent Market Insights

North America is expected to hold dominant position in the global ambulatory infusion center market during the forecast period, owing to key companies focusing on expanding service facilities of ambulatory infusion for the treatment of various diseases such as cancer and others. For instance, in May 2018, Keck Medicine of University of Southern California's medical enterprise (USC), announced expansion of its network of ambulatory clinics with a new location in Southern California. The new facility offers a wide range of primary care and specialty services such as ambulatory infusion services for people suffering from various disorders such as cancer, gastrointestinal disorders.

Key Players

Major players operating in the global ambulatory infusion center market include Option Care Health, PharmaScript, Cleveland Clinic, Stoughton Health, Coram CVS, Hattiesburg Clinic, UnitedHealth Group, UK HealthCare, CHI Health, PharMerica, Beacon Health System, Inc., Arnot Health, Inc., IVX Health, and Precision Healthcare.

The ambulatory infusion is administration of medications and body fluids for various disorders such as neurological disorders, cancers, chronic inflammation disorders, and nutrition support. The ambulatory infusion centers provide administration of various medication such as antibiotic, chemotherapy, pain management drugs, and others to the patients.

Market Dynamics

Key players are focusing on technological advancement in ambulatory infusion systems to strengthen their position in the global ambulatory infusion center market. For instance, in October 2020, Zyno Solutions, a company focusing on providing Intelligent IV infusion system, launched Nimbus Ambulatory Infusion Pump and the Z-800F Infusion Pump at Immunoglobulin National Society (IgNS) Virtual Conference on October 22-26. Nimbus ambulatory infusion pump is small in size, cost effective, and can meet several ambulatory infusion applications such as bleeding disorders, chronic inflammatory disorders, and cancer.   

Key features of the study:

  • This report studies the current scenario as well as the future potential of the global ambulatory infusion center market. The market for is segmented on basis of therapy type, application, distribution channel, and region.
  • This report provides in-depth analysis of the global ambulatory infusion center market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2020-2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
  • It profiles leading players in the global ambulatory infusion center market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
  • The global ambulatory infusion center market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global ambulatory infusion center market

Detailed Segmentation:

  • Global Ambulatory Infusion Center Market, By Therapy Type:
    • Blood Product Infusion
    • Iron Therapy
    • Steroid Infusion
    • Immunoglobulin Therapy
    • Therapeutic Phlebotomy
    • Plasmapheresis
    • Clotting Factor Replacement Therapy
    • Others
  • Global Ambulatory Infusion Center Market, By Application:
    • Chronic Inflammatory Disorders
    • Neurological Disorders
    • Cancers
    • Nutrition Support
    • Gastro-intestinal Disorders
  • Global Ambulatory Infusion Center Market, By Distribution Channel :
    • Hospital
    • Clinics
    • Home Infusion  
  • Global Ambulatory Infusion Center Market, By Region:
    • North America
      • By Therapy Type:
        • Blood Product Infusion
        •  Iron Therapy
        •  Steroid Infusion
        •  Immunoglobulin Therapy
        •  Therapeutic Phlebotomy
        • Plasmapheresis
        • Clotting Factor Replacement Therapy
        • Others
      • By Application:
        • Chronic Inflammatory Disorders
        • Neurological Disorders
        • Cancers
        • Nutrition Support
        • Gastro-intestinal Disorders
      • By Distribution Channel :
        • Hospital
        • Clinics
        • Home Infusion  
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Therapy Type:
        • Blood Product Infusion
        • Iron Therapy
        • Steroid Infusion
        • Immunoglobulin Therapy
        • Therapeutic Phlebotomy
        • Plasmapheresis
        • Clotting Factor Replacement Therapy
        • Others
      • By Application:
        • Chronic Inflammatory Disorders
        • Neurological Disorders
        • Cancers
        • Nutrition Support
        • Gastro-intestinal Disorders
      • By Distribution Channel :
        • Hospital
        • Clinics
        • Home Infusion
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Therapy Type:
        • Blood Product Infusion
        • Iron Therapy
        • Steroid Infusion
        • Immunoglobulin Therapy
        • Therapeutic Phlebotomy
        • Plasmapheresis
        • Clotting Factor Replacement Therapy
        • Others
      • By Application:
        • Chronic Inflammatory Disorders
        • Neurological Disorders
        • Cancers
        • Nutrition Support
        • Gastro-intestinal Disorders
      • By Distribution Channel :
        • Hospital
        • Clinics
        • Home Infusion
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Therapy Type:
        • Blood Product Infusion
        •  Iron Therapy
        •  Steroid Infusion
        •  Immunoglobulin Therapy
        •  Therapeutic Phlebotomy
        •  Plasmapheresis
        • Clotting Factor Replacement Therapy
        • Others
      • By Application:
        • Chronic Inflammatory Disorders
        • Neurological Disorders
        • Cancers
        • Nutrition Support
        • Gastro-intestinal Disorders
      • By Distribution Channel :
        • Hospital
        • Clinics
        • Home Infusion
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Therapy Type:
        • Blood Product Infusion
        • Iron Therapy
        • Steroid Infusion
        • Immunoglobulin Therapy
        • Therapeutic Phlebotomy
        • Plasmapheresis
        • Clotting Factor Replacement Therapy
        • Others
      • By Application:
        • Chronic Inflammatory Disorders
        • Neurological Disorders
        • Cancers
        • Nutrition Support
        • Gastro-intestinal Disorders
      • By Distribution Channel :
        • Hospital
        • Clinics
        • Home Infusion
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Therapy Type:
        • Blood Product Infusion
        •  Iron Therapy
        •  Steroid Infusion
        •  Immunoglobulin Therapy
        •  Therapeutic Phlebotomy
        •  Plasmapheresis
        • Clotting Factor Replacement Therapy
        • Others
      • By Application:
        • Chronic Inflammatory Disorders
        • Neurological Disorders
        • Cancers
        • Nutrition Support
        • Gastro-intestinal Disorders
      • By Distribution Channel :
        • Hospital
        • Clinics
        • Home Infusion
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Option Care Health.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • PharmaScript
    • Cleveland Clinic
    • Stoughton Health
    • Coram CVS
    • Hattiesburg Clinic
    • UnitedHealth Group
    • UK HealthCare
    • CHI Health
    • PharMerica
    • Beacon Health System, Inc.
    • Arnot Health, Inc.
    • IVX Health
    • Precision Healthcare

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Therapy Type
      • Market Snapshot, By Application 
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Drivers
    • Restraints
    • Opportunities
    • Impact Analysis
    • Key Developments
    • New Product Launches/Approvals
    • Merger-Acquisition Scenario
    • Regulatory Scenario
    • Pipeline Analysis
    • Epidemiology
    • PEST Analysis
    • Reimbursement
  4. Global Ambulatory Infusion Center Market - Impact of COVID-19 Pandemic
    • Government Initiative to Combat Covid-19
    • Safety Precaution Guidelines for Ambulatory Infusion Procedures.
  5. Global Ambulatory Infusion Center Market, By Therapy Type, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        •  Blood Product Infusion
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        •  Iron Therapy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        •  Steroid Infusion
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        •  Immunoglobulin Therapy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        •  Therapeutic Phlebotomy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        •  Plasmapheresis
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Clotting Factor Replacement Therapy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  6. Global Ambulatory Infusion Center Market, By Application, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        •  Chronic Inflammatory Disorders
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Neurological Disorders
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Cancers
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Nutrition Support
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Gastro-intestinal Disorders
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  7. Global Ambulatory Infusion Center Market, By Distribution Channel, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Hospital
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Clinics
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Home Infusion
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  8. Global Ambulatory Infusion Center Market, By Region, 2016–2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Country, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Countries, 2017–2027
    • North America
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • Germany
        • U.K.
        • France       
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Therapy Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016–2027 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Company Profiles
      • Option Care Health
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • PharmaScript
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cleveland Clinic
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Stoughton Health
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Coram CVS
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hattiesburg Clinic
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • UnitedHealth Group
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • UK HealthCare
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • CHI Health
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • PharMerica
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Beacon Health System, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Arnot Health, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • IVX Health
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Precision Healthcare
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies

*Browse 33 market data tables and 32 figures on " Ambulatory Infusion Center Market – Global forecast to 2027”.

Frequently Asked Questions

The global ambulatory infusion center market size is estimated to be valued at US$ 47,013.5 million in 2020 and is expected to exhibit a CAGR of 9.0% between 2020 and 2027.
Increasing prevalence of various diseases such as cancer, multiple sclerosis, and gastrointestinal diseases globally and key players focusing on inorganic growth strategies such as mergers and acquisitions are the factors that are expected to drive growth of the global ambulatory infusion center market.
Blood product infusion segment is estimated to hold major market share in the global ambulatory infusion center market during the forecast period, owing to increasing prevalence of blood disorders such as anemia in individuals.
Cancers segment is estimated to hold major market share in the global ambulatory infusion center market during the forecast period, owing to increasing prevalence of various cancers such as lung cancer, blood cancer, globally.
North America is estimated to generate largest revenue share in 2020 in the global ambulatory infusion center market.
Ambulatory infusion leads to various side effects such as itching at infusion site, flushing, nausea, and cough in patients are the key factors that are expected to hamper growth of the market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner